Clinical trial · Interventional
PR-CEAL: Community Outreach Engagement Group
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The United States Preventive Services Task Force (USPSTF) recommends regular screenings for breast, cervical, and colorectal cancer. The COVID-19 pandemic has disrupted health screening practices, leading to a decrease in cancer screenings among the United States including Puerto Rico. This has been attributed to unwillingness, distrust, and insecurity related to accessing healthcare services. To overcome these challenges, a collaboration between PR-CEAL's Community Outreach Engagement Group (COEG), academic researchers, healthcare institutions, and community-based organizations proposed to engage in different community activities throughout the island. In these events, investigators conducted a single blinded community-based Randomized Clinical Trial (RCT) regarding cancer screening practices in women 21 through 75 years. The community-based RCT employed a mixed-method design to gain insights into the perception of health and cancer screening status of participants regarding breast, uterine (cervical), and colorectal cancer. Data was collected through in person interviews and two follow up phone calls, enabling the researchers to obtain valuable sociodemographic information, assessing cancer screening history, and identifying existing barriers. The hypothesis of this study is that implementing evidence-based intervention at community settings across Puerto Rico will have a significant positive effect on cancer screening rates among non-adherent patients. By identifying and adapting the Prevention Care Management for Cancer Screening intervention and leveraging the expertise of the National Cancer Institute, the study aimed to improve screening rates, address barriers that hinder or delay screenings, and raise awareness about the importance of early detection.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Prevention | — | UNRESOLVED | — |
| Cervical Cancer Prevention | — | UNRESOLVED | — |
| Colorectal Cancer Prevention | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cancer Screening Information | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Physical Activity and Mental Health Information
- description
- The control group (n=250) received physical activity and mindfulness materials. Two follow-up calls, at four- week intervals each, assessed screening status for all participants. Once the study concluded, cancer information was sent to participants by certified mail.
- type
- EXPERIMENTAL
- label
- Cancer Screening Information
- description
- The intervention group (n=250) received educational materials that included: screening center details, and reminders related to cancer screening. Two follow-up calls, at four-week intervals each, assessed screening status for all participants.
- interventionNames
- Behavioral: Cancer Screening Information
Primary outcomes (1)
- measure
- Number of participants who compelled with cancer screening test
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Women * Between 21 and 75 years old * Participant is overdue in at least one cancer screening (breast, cervical or colorectal), according to the USPTF guidelines. * Participants that have not reported any cognitive, mental or physical limitation. * Ability to read. * Access to a telephone. * Participants that are not in active cancer treatment. Exclusion Criteria: * Male * Women younger than 21 years or older than 75 years. * Participants that are not overdue in any cancer screening (breast, cervical or colorectal), according to the USPTF guidelines. * Participants that are cognitive, mental or physically limited. * Participants who are not able to read. * Participants who don't have access to a telephone. * Participants that are in active cancer treatment.
References
Publications (0)
Data not yet available